These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 26472223

  • 1. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
    Liu X, Henkel AS, LeCuyer BE, Schipma MJ, Anderson KA, Green RM.
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec 15; 309(12):G965-74. PubMed ID: 26472223
    [Abstract] [Full Text] [Related]

  • 2. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA, Singh BK, Adami E, Viswanathan S, Dong J, D'Agostino GA, Ng B, Lim WW, Tan J, Paleja BS, Tripathi M, Lim SY, Shekeran SG, Chothani SP, Rabes A, Sombetzki M, Bruinstroop E, Min LP, Sinha RA, Albani S, Yen PM, Schafer S, Cook SA.
    Gastroenterology; 2019 Sep 15; 157(3):777-792.e14. PubMed ID: 31078624
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of liver injury in high fat sugar diet fed mice that lack hepatocyte X-box binding protein 1.
    Liu X, Taylor SA, Gromer KD, Zhang D, Hubchak SC, LeCuyer BE, Iwawaki T, Shi Z, Rockey DC, Green RM.
    PLoS One; 2022 Sep 15; 17(1):e0261789. PubMed ID: 35030194
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
    Ganz M, Csak T, Szabo G.
    World J Gastroenterol; 2014 Jul 14; 20(26):8525-34. PubMed ID: 25024607
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
    Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, Charlton MR, Shah VH, Malhi H, Gores GJ.
    Gastroenterology; 2016 Apr 14; 150(4):956-67. PubMed ID: 26764184
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis.
    Jiang S, Yan C, Fang QC, Shao ML, Zhang YL, Liu Y, Deng YP, Shan B, Liu JQ, Li HT, Yang L, Zhou J, Dai Z, Liu Y, Jia WP.
    J Biol Chem; 2014 Oct 24; 289(43):29751-65. PubMed ID: 25170079
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of dietary fat to produce non-alcoholic fatty liver in the rat.
    Ahmed U, Redgrave TG, Oates PS.
    J Gastroenterol Hepatol; 2009 Aug 24; 24(8):1463-71. PubMed ID: 19702912
    [Abstract] [Full Text] [Related]

  • 17. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
    Martínez L, Torres S, Baulies A, Alarcón-Vila C, Elena M, Fabriàs G, Casas J, Caballeria J, Fernandez-Checa JC, García-Ruiz C.
    Oncotarget; 2015 Dec 08; 6(39):41479-96. PubMed ID: 26539645
    [Abstract] [Full Text] [Related]

  • 18. C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis.
    Rahman K, Liu Y, Kumar P, Smith T, Thorn NE, Farris AB, Anania FA.
    Lab Invest; 2016 Aug 08; 96(8):895-908. PubMed ID: 27239734
    [Abstract] [Full Text] [Related]

  • 19. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    Takahara I, Akazawa Y, Tabuchi M, Matsuda K, Miyaaki H, Kido Y, Kanda Y, Taura N, Ohnita K, Takeshima F, Sakai Y, Eguchi S, Nakashima M, Nakao K.
    PLoS One; 2017 Aug 08; 12(3):e0170591. PubMed ID: 28278289
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.